50 Patients Already Treated
Already treated using the RETROMapping system with Tau20 EP stimulator.
2 Clinical Trials in Progress
The British Heart Foundation are supporting two randomized controlled studies.
A revolutionary approach to Atrial Fibrillation therapy
Retro-Mapping software embedded in Tau 20 aims to transform the success rate of Atrial Fibrillation ablation with real-time mapping of activatation allows physicians never-before seen insights into Atrial Fibrillation
Expert Medical Products for Atrial Fibrillation Treatment.
TauRhythm Therapies is approaching the atrial fibrillation market with a set of tools that dovetail with existing market-leading technologies to provide a wider scope of treatment to improve lives. The Tau 20 is a compact EP stimulator and recording system. It can be used during sinus rhythm to locate ganglionated plexi that trigger AF. Alternatively, when the patient is in AF, the featured RETROmapping software can perfrom real-time activation mapping of AF to identify potential sources.
Proprietary RETRO-Map Technology
Custom algorithms process electrode data in real-time to provide immediate feedback to physicians on activation origination and electrode contact strength
Developed at Imperial College, London
Developed by a team of leading electrophysiologists and electrcical engineers
Prof. Prapa Kanagaratnam
Founder & Director
Invented and licensed Ripple Mapping to Johnson & Johnson. Helped multiple start-ups though early-stage patient studies
Dr. Nick Linton
Founder & Director
Developed software system used by LiDCO™ ($200M float), widely used in intensive care medicine, and Ripple Mapping.
Prof. Manos Drakakis
Founder & Director
Developed ultra-low-power processor for advanced medical products such as cochlear and optobionic implants and brain instruments.
Dr. Burak Temelkuran
Founder & Director
Previous spinout from Massachusetts Institute of Technology with 15 years’ experience bridging engineering and medical sciences.
Publications
Backed by peer-reviewed research and clinical studies
Coyle C, Kanella I, Mann I, Qureshi N, Linton NWF, Kanagaratnam P. J Cardiovasc Electrophysiol. 2024 Mar;35(3):557-568. doi: 10.1111/jce.16116
Read PaperMann I, Linton NWF, Coyle C, Howard JP, Fudge M, Lim E, Qureshi N, Koa-Wing M, Whinnett Z, Lim PB, Ng FS, Peters NS, Francis DP, Kanagaratnam P. Circ Arrhythm Electrophysiol. 2021 Jun;14(6):e009602. doi: 10.1161/CIRCEP.121.009602.
Read PaperMann I, Coyle C, Qureshi N, Nagy SZ, Koa-Wing M, Lim PB, Francis DP, Whinnett Z, Peters NS, Kanagaratnam P, Linton NWF. J Cardiovasc Electrophysiol. 2019 Sep;30(9):1464-1474. doi: 10.1111/jce.14033.
Read PaperSmith S, Coyle C, Dhutia N, Kanagaratnam P, Linton NWF. J Cardiovasc Electrophysiol. 2023 May;34(5):1119-1126. doi: 10.1111/jce.15877
Read PaperCoyle C, Koutsoftidis S, Kim MY, Porter B, Keene D, Luther V, Handa B, Kay J, Lim E, Malcolme-Lawes L, Koa-Wing M, Lim PB, Whinnett ZI, Ng FS, Qureshi N, Peters NS, Linton NWF, Drakakis E, Kanagaratnam P. J Interv Card Electrophysiol. 2023 Mar 3. doi: 10.1007/s10840-023-01517-9.
Read PaperKim MY, Coyle C, Tomlinson DR, Sikkel MB, Sohaib A, Luther V, Leong KM, Malcolme-Lawes L, Low B, Sandler B, Lim E, Todd M, Fudge M, Wright IJ, Koa-Wing M, Ng FS, Qureshi NA, Whinnett ZI, Peters NS, Newcomb D, Wood C, Dhillon G, Hunter RJ, Lim PB, Linton NWF, Kanagaratnam P. Heart Rhythm. 2022 Apr;19(4):516-524. doi: 10.1016/j.hrthm.2021.12.010.
Read PaperKim MY, Lim PB, Coyle C, Sandler B, Koa-Wing M, Kanagaratnam P. JACC Case Rep. 2020 Oct 21;2(12):2004-2009. doi: 10.1016/j.jaccas.2020.07.058.
Read PaperSandler B, Kim MY, Sikkel MB, Malcolme-Lawes L, Koa-Wing M, Whinnett ZI, Coyle C, Linton NWF, Lim PB, Kanagaratnam P; other members of the Imperial College London, Cardiovascular Study Group/Consortium. J Cardiovasc Electrophysiol. 2021 Feb;32(2):235-244. doi: 10.1111/jce.14870.
Read Paper